Bullish
Galmed Pharmaceuticals is set to acquire Colospan for $4.5 million, comprising $2.5 million in cash and $2 million in Galmed shares. This acquisition ...
Bullish
Incyte, Galmed Pharmaceuticals, and Johnson & Johnson recently announced a combined total of $3 billion in acquisitions. Incyte purchased Vega Therape...
Bullish
Galmed Pharmaceuticals and Tissue Dynamics announced positive preclinical results for a combination therapy involving Aramchol Meglumine and a selecti...
Bullish
Tissue Dynamics and Galmed Pharmaceuticals have identified a previously unrecognized metabolic pathway responsible for cardiac fibrosis and heart fail...